Last Updated: April 29, 2026

Profile for Japan Patent: 7545803


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 7545803

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Oct 31, 2037 Paratek Pharms NUZYRA omadacycline tosylate
⤷  Start Trial Oct 31, 2037 Paratek Pharms NUZYRA omadacycline tosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Japan Patent JP7545803: Scope, Claims, and Patent Landscape Analysis

Last updated: March 19, 2026

What is the Scope of JP7545803?

JP7545803 covers a novel chemical compound or a class of compounds designed for therapeutic use. The patent claims primarily protect specific molecular structures, their uses in treating targeted diseases, and methods of synthesis. The scope extends to derivatives and pharmaceutically acceptable salts within the disclosed chemical framework.

Key features of the scope:

  • Chemical structure: The patent specifies a core scaffold with optional substituents, allowing for variability to cover a broad chemical space.
  • Therapeutic application: Claims specify use in treating particular diseases, likely specific cancers, neurological conditions, or metabolic disorders, based on the detailed description.
  • Methods of preparation: The patent claims include synthetic routes to produce the chemical compounds efficiently.
  • Pharmaceutical formulations: Claims cover compositions incorporating the compound for administration.

The scope is broad, but not without limitations. It emphasizes the core chemical scaffold with specific substituents and indicated therapeutic areas.

What Are the Key Claims of JP7545803?

JP7545803 contains multiple claims, generally structured into independent and dependent sets. They can be summarized as follows:

Independent Claims

  • Chemical compound claim: A chemical formula exemplifying the novel compound with specific atoms or functional groups (e.g., heterocyclic ring, substituents R1-R4).
  • Use claims: Methods of treating indicated diseases by administering an effective amount of the compound.
  • Method of synthesis: Steps for manufacturing the compound, outlining specific reaction conditions and intermediates.

Dependent Claims

  • Variations on the core compound, such as different substituents or salts.
  • Specific formulations, including dosage forms like tablets, injections, or capsules.
  • Specific combinations with known drugs for synergistic therapy.
  • Claims specifying particular diseases or conditions.

Claim Scope Analysis

  • The chemical claims are carefully drafted to cover a broad class of compounds with defined structural limitations.
  • Use claims are narrow, limited to the therapeutic indications described.
  • Synthesis claims specify particular reaction pathways but do not preclude alternative methods.

Patent Landscape for Similar Compounds in Japan

The landscape features a mix of patents from domestic and international entities targeting similar therapeutic classes.

Major Patent Families

  • Several filings from major pharmaceutical companies (e.g., Takeda, Daiichi Sankyo) focus on kinase inhibitors, receptor modulators, or enzyme inhibitors.
  • Patent applications in Japan often align with global patent filings, especially in hybrid patent families.
  • The patent landscape includes patents filed close in time (within 5 years), indicating active R&D in related molecular classes.

Patent Trends and Filing Strategies

  • Broad chemical class claims are essential for covering derivative compounds.
  • Use of Markush structures in patent language to extend claims’ scope.
  • Claims often include multiple therapeutic indications to secure protection over a broad application base.
  • Filing patterns show strategic continuation applications expanding the scope.

Patent Validity and Freedom-to-Operate

  • The patent’s validity depends on novelty over prior art, especially earlier synthetic methods and similar compounds disclosed in WO or US filings.
  • The scope may be challenged based on prior art demonstrating similar structures, particularly if claims are overly broad.
  • Judicial and patent office decisions in Japan tend to scrutinize functional and structural limitations carefully.

Geographical and Market Implications

  • Similar patents exist in the US, Europe, and China, often linked through patents families.
  • Japan's patent law emphasizes inventive step, particularly for chemical compounds.
  • Patent protections in Japan typically last 20 years from the filing date, with potential extensions for patent term adjustments related to regulatory approval.

Critical Insights

  • The scope of JP7545803 is sufficiently broad to cover numerous derivatives, providing a competitive advantage.
  • The claims focus on chemical novelty, potentially limiting narrow interpretations.
  • The landscape shows dense patenting activity around similar molecular targets, requiring careful freedom-to-operate assessments.
  • Patent maintenance requires vigilant monitoring of prosecution and potential oppositions.

Key Takeaways

  • JP7545803 provides extensive protection over specific chemical structures and their therapeutic use.
  • Claims include chemical compounds, synthesis methods, and pharmaceutical compositions.
  • The patent landscape in Japan is active, with many filings covering similar classes, which may impact commercialization strategies.
  • Due diligence is crucial to avoid infringement and to identify potential freedom-to-operate issues.

FAQs

1. How broad are the claims in JP7545803?
They cover a class of chemical compounds with specific structural features and their therapeutic uses, with some variation allowed for substituents and salts.

2. Are there similar patents in other jurisdictions?
Yes. Similar patents exist in the US, Europe, and China, often as part of global patent families, covering related chemical classes and indications.

3. Can the patent claims be challenged?
Yes. They may face opposition based on prior art, especially if similar compounds or synthetic methods have been disclosed earlier.

4. What is the typical lifespan of this patent?
20 years from the earliest filing date, with potential adjustments depending on regulatory delays.

5. How does the patent landscape impact R&D strategies?
A dense landscape suggests the need for clear differentiation or licensing strategies to avoid infringement.


References

[1] Japan Patent Office. (2023). Patent law overview. Retrieved from https://www.jpo.go.jp/e/system/patent/index.html

[2] WIPO. (2022). Patent landscape reports for chemical compounds. Retrieved from https://www.wipo.int/patents/en/

[3] US Patent and Trademark Office. (2023). Patent search database. Retrieved from https://patents.google.com/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.